Clinical trial
Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes…
NCT00201292 · National Health Research Institutes, Taiwan, Other · Unknown status
Key facts
| NCT number | NCT00201292 |
|---|---|
| Title | Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD) |
| Official title | Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD) |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | Taipei City Hospital Mackay Memorial Hospital Department of Health Yuli Hospital |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Metabolic Syndrome, Diabetes |
| Enrollment | 1,350 |
| Start date | Mar 1, 2005 |
| Completion | Oct 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 15, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: